Pharmafile Logo

Inizio strengthens executive team with new leadership appointments

September 24, 2025 |  

Inizio has appointed Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer, strengthening its executive leadership to drive innovation, digital transformation, and Intelligent Commercialization™ across the health and life sciences sector.

MK-Gavin-Inizio

We are proud to announce the strategic appointment of two senior executives to our leadership team – advancing innovation, operational excellence, and digital transformation across the organization. 

Joining the Executive Team are Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer. These appointments strengthen our ability to deliver Intelligent Commercialization™ – seamlessly connecting science, technology, and human expertise to unlock value across every stage of the health and life sciences journey. 

Mary-Kate McGarry appointed Chief Strategy & Innovation Officer 

Mary-Kate, who served as Vice President, Global & Corporate Strategy since 2022, now joins the Executive Team as Chief Strategy & Innovation Officer. In this role, she will lead corporate strategy, innovation, global marketing, and brand development. 

Since joining Inizio in 2021, following the merger of UDG Healthcare and Huntsworth, Mary-Kate has played a pivotal role in shaping the integrated corporate strategy and aligning strategic priorities across the business. As Chief Strategy & Innovation Officer, she will accelerate our Intelligent Commercialization™ approach – harnessing innovation, strategy realization, and AI-driven transformation, with a focus on: 

  • Advancing strategy realization across the Group 
  • Leading Gen AI platform investment and development 
  • Driving colleague enablement and internal innovation 
  • Strengthening global brand positioning and go-to-market alignment 

Prior to joining Inizio, Mary-Kate built a tenured career in management consulting, working with executive teams across healthcare, financial services, and government sectors to lead large-scale transformation and growth programs. 

Gavin McShera joins the Executive Team as Chief Information Officer 

Gavin McShera, who has served as Inizio’s CIO since 2021, now joins our Executive Team. With three decades of global experience in technology leadership across healthcare, retail, finance, aviation, and the public sector, Gavin continues to oversee our enterprise technology strategy, while playing a broader role in shaping organizational leadership. 

As CIO, Gavin oversees our enterprise technology strategy, focusing on: 

  • Driving innovation through scalable tech infrastructure 
  • Enhancing operational efficiency 
  • Leading Inizio’s global cybersecurity strategy 
  • Promoting a culture of data privacy and security awareness 

Before joining UDG Healthcare in 2021, Gavin served as Group CIO at Applegreen PLC and held roles at Microsoft and as an independent consultant. 

A future-focused leadership team 

With these appointments, we reinforce our commitment to being a market-leading, trusted commercialization partner for health and life sciences companies worldwide. At Inizio, we bring together data, technology, and multidisciplinary expertise to simplify complexity, reduce risk, and deliver consistent value across the commercialization journey. 

Learn more about our leadership team.  

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Webinar: Uncovering hidden insights into patient compliance

Pharma companies are increasingly looking for ways to provide “beyond the pill" services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment...

Webinar: The patient journey: Time to look beyond the physician?

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

Webinar: Ensuring an actionable segmentation

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.

Webcast: Leveraging the ASEAN opportunities

Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.

Webcast: Biosimilars: Friend or Foe to Healthcare?

Understanding the opportunities for biosimilars and the threats to innovator biologics

Webinar: Understanding the patient journey in China

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers...

Webinar: Capturing “in-the-moment” patient and physician insights

Utilising the benefits of mobile technology

Webinar: Observational Research

Presenting a window on the world of your customer

Webinar: The Brazil Conundrum

Conducting research in one of the world's largest pharma markets

Webinar: Demand calibration: What’s inside the black box?

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...